Biotron Limited

Share · AU000000BIT4 (OTC)

Overview

No Price

Closing Price OTC 08.12.2025: 0,001 USD

08.12.2025 21:00

Current Prices from Biotron Limited

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
UTC	BITRF	USD	08.12.2025 21:00	0,001 USD	0,00 USD

Company Profile for Biotron Limited Share

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia.

Get up to date insights from finAgent about Biotron Limited

Company Data

Name Biotron Limited

Company Biotron Limited

Website https://www.biotron.com.au

Primary Exchange

UTC

ISIN AU000000BIT4

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Michelle Miller GCertAppFin,

Country Australia

Currency USD

Employees -

Address 66 Hunter Street, 2000 Sydney

IPO Date 2013-03-22

Ticker Symbols

Name	Symbol
Over The Counter	BITRF

More Shares

Investors who hold Biotron Limited also have the following shares in their portfolio:

CAPITAL HOSPITALS (ISSUER) PLC 1.7030% A IN LD GT SEC BD30/09/46 £ BR Bond

DEKA MSCI EUR.EX EMU U.E. ETF

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog